Gaciong Z, Paczek L, Kobryń A, Górski A
Arch Immunol Ther Exp (Warsz). 1985;33(2):311-7.
Thymosin (TFX) administered in mice does not alter their primary IgM humoral responses, while it significantly increases the number of IgG plaque-forming cells and IgM PFC during the secondary response. In the thymectomized mice, thymosin partially restores primary and secondary IgM responses, but IgM production remains low.